Plus Therapeutics Inc [NASDAQ: PSTV] traded at a high on Tuesday, posting a 12.60 gain after which it closed the day’ session at $1.43.
The results of the trading session contributed to over 23476451 shares changing hands. Over the past one week, the price volatility of Plus Therapeutics Inc stands at 82.69% while the volatility over the past one month is 37.29%.
The market cap for PSTV stock reached $8.43 million, with 5.90 million shares outstanding and 5.75 million shares in the current float. Compared to the average trading volume of 8.12M shares, PSTV reached a trading volume of 23476451 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Plus Therapeutics Inc [PSTV]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PSTV shares is $10.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PSTV stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Plus Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 25, 2021. While these analysts kept the previous recommendation, Maxim Group raised their target price to Buy. The new note on the price target was released on October 16, 2020, representing the official price target for Plus Therapeutics Inc stock.
The Average True Range (ATR) for Plus Therapeutics Inc is set at 0.30, with the Price to Sales ratio for PSTV stock in the period of the last 12 months amounting to 1.47.
How has PSTV stock performed recently?
Plus Therapeutics Inc [PSTV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 373.20. With this latest performance, PSTV shares gained by 15.66% in over the last four-week period, additionally plugging by 1.42% over the last 6 months – not to mention a drop of -17.34% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PSTV stock in for the last two-week period is set at 58.41, with the RSI for the last a single of trading hit 61.03, and the three-weeks RSI is set at 56.66 for Plus Therapeutics Inc [PSTV]. The present Moving Average for the last 50 days of trading for this stock 1.1424, while it was recorded at 1.2120 for the last single week of trading, and 1.4437 for the last 200 days.
Plus Therapeutics Inc [PSTV]: Deeper insight into the fundamentals
Plus Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.44 and a Current Ratio set at 0.44.
Earnings analysis for Plus Therapeutics Inc [PSTV]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PSTV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Plus Therapeutics Inc go to 29.07%.
